Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

A group has developed therapies that show promise for treating cancer and various other conditions.

Skin issues can indicate immune system problems.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Type I interferons play a key role in the development of various skin diseases.

The new system can grow hair in the lab and test hair growth treatments.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.